Very positive comments from the MD. They have already commenced sharing the results with large pharma companies!!
Makes perfect sense to sell now....lol
It's back to where it was, before yesterday's announcement.
I always find ASX investors to be the best!!
“With these excellent results, we believe we have answered in the best way possible the key clinical questions that our large pharma company partners have been asking about AD-214,”
“The molecule is now prepared for Phase II clinical studies, a significant milestone for AdAlta.”
“We have already commenced the process of sharing these latest results with our potential partners with a view to progressing a licensing or asset financing transaction in the near term.”
“Such a transaction would enable AD-214 to advance to Phase II clinical trials in IPF to provide a new option for patients with this debilitating and fatal disease as well as providing a return on our investment to date.”
1AD Price at posting:
2.6¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)